The Journal of Pediatrics
Volume 157, Issue 1 , Pages 171-172 , July 2010

Topical intranasal steroids do not benefit children with persistent middle ear effusion

References 

  1. Thomas CL, Simpson S, Butler C, van der Voort J. Oral or topical nasal steroids for hearing loss associated with otitis media with effusion in children. Cochrane Database Syst Rev. 2006;(3):CD001935
  2. Cengel S, Akyol MU. The role of topical nasal steroids in the treatment of children with otitis media with effusion and/or adenoid hypertrophy. Int J Pediatr Otorhinolaryngol. 2006;70:639–645
  3. Van Balen FAM, de Melker RA, Touw-Otten FW. Double-blind randomised trial of co-amoxiclav versus placebo for persistent otitis media with effusion in general practice. Lancet. 1996;348:713–716

PII: S0022-3476(10)00405-1

doi: 10.1016/j.jpeds.2010.05.009

The Journal of Pediatrics
Volume 157, Issue 1 , Pages 171-172 , July 2010